Neurology News

SAN DIEGO — Physicians should emphasize the importance of diet and lifestyle change in patients with MS and consider home environment, cultural challenges and other factors when making recommendations, a presenter noted at ACTRIMS 2023.

Adults with obstructive sleep apnea faced elevated risks for developing COVID-19 and experiencing COVID-19-related complications, according to study results published in Thorax.

SAN DIEGO — Variations in satisfaction and confidence in MRI reports may lead to significant variability in the clinical decisions made by neurologists specializing in MS care, according to a poster from ACTRIMS 2023.

SAN DIEGO — Black individuals with MS were more disabled than white patients, with higher rates of ambulatory assistance, hospitalization and vision loss driving the difference, per a poster at ACTRIMS 2023.

The FDA has approved Skyclarys, Reata Pharmaceuticals’ oral, once-daily medication to treat Friedreich’s ataxia in people aged 16 years and older.

A noninvasive focused ultrasound technology was used in an FDA-approved clinical trial to treat Alzheimer’s disease, according to a press release.

SAN DIEGO — A multimodal approach to analyzing MS lesions in fresh brain samples provides a clearer path to understanding disease processes that lead to lesion formation, according to a presenter at ACTRIMS 2023.

The Consolidated Appropriations Act of 2023, enacted on Dec. 29, 2022, includes the Secure 2.0 Act of 2022, which contains many provisions designed to expand retirement coverage, increase retirement savings and clarify retirement rules.

Because practice management systems and electronic health records originally were designed to support accurate billing for subsequent reimbursement, fundamental changes to practice patterns are slow to enter clinical practices.

SAN DIEGO — Intermittent calorie restriction in patients with relapsing-remitting MS was associated with positive physical and cognitive outcomes after 12 weeks compared with an unrestricted diet, according to a researcher at ACTRIMS 2023.